![Expert Q&A: Enhancing Clinical Labs through Advanced Data Analytics](https://www.g2intelligence.com/wp-content/uploads/2023/12/Jan24.CDI_.Expert_Q-A-Data-Analytics-Clifford.BK-iStock-1483251783_1100x800-1080x675.jpg)
Expert Q&A: Enhancing Clinical Labs through Advanced Data Analytics
Lisa-Jean Clifford of Gestalt Diagnostics, discusses key trends, challenges, and solutions in data analytics for clinical labs.
Lisa-Jean Clifford of Gestalt Diagnostics, discusses key trends, challenges, and solutions in data analytics for clinical labs.
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Five strategies for lab leaders to focus on to tackle the challenges of today and ensure future success.
Standard 1910.1450 requires labs to have a chemical hygiene plan.
Approaching laboratory safety from a diversity, equity, inclusion, and accessibility perspective.
Artificial intelligence models have a valuable role to play in each phase of the total testing process.
With US STI cases continuing to climb to numbers not seen in decades, a recent FDA approval comes at an opportune moment.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
The basics of how the OSHA inspection process works and how laboratories can successfully navigate it.
Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.